Evidence map›Paper›PMID 39969028›Full record

ArticleJournal of applied clinical medical physics2025

Impact of bladder volume and bladder shape on radiotherapy consistency and treatment interruption in prostate cancer patients.

Sijuan Huang, Ting Li, Yujun Guo, Xiuying Mai, Xinyi Dai, Manli Wu, Mengxue He, Yang Liu, Liru He, Xin Yang

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sijuan HuangState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Ting LiState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.ORCID https://orcid.org/0009-0007-0534-7328
Yujun GuoState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Xiuying MaiState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Xinyi DaiDepartment of Liver Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Manli WuState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Mengxue HeState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Yang LiuState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Liru HeState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.
Xin YangState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou, Guangdong, P. R. China.

Funding

Beijing Xisike Clinical Oncology Research Foundation Y-Young2023-0156Beijing Xisike Clinical Oncology Research Foundation Y-Young2024-0538Guangdong Esophageal Cancer Institute Science and Technology Program Q202221Guangdong Esophageal Cancer Institute Science and Technology Program Q202311Key technology research on prostate adaptive radiotherapy based on CT integrated Linear Accelerator qnrc-2022-15Scientific Research Cooperation Projects of UIH&SYSUCC ZDZL-UIH-2022006United Laboratory of Frontier Radiotherapy Technology Fund HT-99982024-0350Youth Innovation Project of Sun Yat-sen University Cancer Center QNYCPY32
6 · The paper itself

Abstract

backgroundTo investigate the effect of bladder volume (BV) and bladder shape on consistency and treatment interruption in prostate cancer radiotherapy (RT).

methodsA total of 275 patients who underwent radical prostate cancer RT in our institution from April 2015 to December 2022 were enrolled. Bladder height, bladder width, and bladder length were defined and recorded. The receiver operating characteristic (ROC) curves were used to evaluate the best cut-off point for bladder shape. Logistic regression analysis was used to analyze the relationship between setup errors and bladder shapes and BV.

resultsBased on the ROC curves for 275 patients, the bladder shapes were classified into three: (a) the elongated bladder, (b) the spherical bladder, and (c) the oval bladder. Sixty-six prostate cancer patients (1611 CBCTs) were randomly selected proportionally. It was found that bladder shape has a greater impact on setup errors than BV (BV: OR = 1.470, p = 0.037; bladder shape: OR = 2.013, p < 0.001), and the setup error of the spherical bladder in anterior-posterior (AP) direction was greater than the others (p < 0.001). In addition, the shape consistency of the spherical bladder was the worst (43.0%) during RT. Compared with the inconsistent group, the group with the same bladder shape had higher consistency in BV

conclusionsMore specific bladder filling requirements should be developed for different bladder shapes. More attention should be paid to the spherical bladder for precise RT.

Indexed as

Organs at RiskProstatic NeoplasmsRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedUrinary BladderAgedCone-Beam Computed TomographyHumansMaleMiddle AgedRadiotherapy DosageRadiotherapy Setup ErrorsRetrospective StudiesTreatment Interruptionbladder shapebladder volumeconsistencyprostate cancersetup errortreatment interruption

Identifiers

PMID39969028
PMCPMC11969095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.